Narayana Hrudayalaya Demerger Wins 99.99% Shareholder Approval

Introduction

Narayana Hrudayalaya Limited has successfully secured overwhelming approval from its stakeholders for a proposed scheme of arrangement with its affiliate, NH Integrated Care Private Limited. The results, declared on April 3, 2026, followed a series of National Company Law Tribunal (NCLT)-convened meetings held a day prior. This decisive approval marks a critical milestone in the company's ongoing corporate restructuring efforts, setting the stage for the final regulatory sanction.

Overwhelming Stakeholder Support

The meetings, conducted via video conference on April 02, 2026, saw participation from equity shareholders, secured creditors, and unsecured creditors. The voting results indicate near-unanimous support across all categories for the demerger plan. The company formally submitted the detailed voting outcomes and the scrutinizer's report to the stock exchanges, fulfilling its obligations under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations.

Equity Shareholder Voting Breakdown

The equity shareholders' meeting was particularly noteworthy, with a high participation rate of 79.25% of the company's total outstanding shares. Support from key investor groups was exceptionally strong. The promoter and promoter group, along with public institutional investors, voted entirely in favour of the resolution. While participation from non-institutional public shareholders was lower at 3.30%, the votes cast were almost entirely in favour of the scheme.

Unanimous Creditor Approval

The company's creditors demonstrated complete confidence in the proposed restructuring. In the meeting for secured creditors, all five creditors on record participated and cast their votes in favour, resulting in a 100% approval. Similarly, the meeting for unsecured creditors saw participation from 14 out of 2,621 creditors on record, who also voted unanimously to approve the scheme.

A Year of Strategic Restructuring

This demerger is part of a broader strategy of corporate restructuring undertaken by Narayana Hrudayalaya. Earlier in the year, on January 19, 2026, the company had secured approvals from its stakeholders for a separate scheme of arrangement involving the amalgamation of its subsidiary, Meridian Medical Research & Hospital Ltd. These back-to-back restructuring initiatives signal a clear focus by the management on optimizing its corporate structure for future growth and operational efficiency.

Financial Health and Market Position

The company's strategic moves are supported by a strong financial position. Credit rating agency ICRA Limited recently reaffirmed its [ICRA]AA (Stable) rating for Narayana Hrudayalaya's credit facilities, amounting to ₹5,195 crore. The rating action cited the company's robust financial performance, including a 15% revenue growth in the first half of fiscal year 2026 and healthy operating margins of 23.5%. Despite significant investments, such as the acquisition of UK-based Practice Plus Group Hospitals, the company has maintained strong financial metrics, including a comfortable interest coverage ratio.

Regulatory Process and Compliance

The entire voting process was conducted in strict adherence to regulatory guidelines. The meetings were presided over by Shri Theerthesh B S, an advocate appointed as Chairman by the NCLT. The e-voting process was managed by Scrutinizer Manali Shah, a Practising Company Secretary. To ensure wide participation, the company facilitated remote e-voting through the NSDL platform from March 30 to April 1, 2026, and also provided e-voting facilities during the meetings. Public notices were duly published in 'The Hindu' and 'Udayavani' newspapers to ensure transparency.

Market Reaction and Stock Performance

While the corporate actions have received strong internal backing, the company's stock has seen some short-term pressure. Over the past month, the stock has declined by 11.25%, and by 4.50% in the last five days. However, this recent performance contrasts with its strong long-term trajectory, with the stock delivering a substantial return of over 288% in the last five years, reflecting investor confidence in its long-term growth story.

Next Steps

With the requisite approvals from shareholders and creditors now secured, Narayana Hrudayalaya will proceed to the next and final stage of the process. The company will file the results and reports with the NCLT, Bengaluru Bench, to seek its final sanction for the scheme of arrangement. This final approval will formally conclude the demerger process, allowing the company to implement the planned restructuring.